Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bis-thiosemicarbazone functions as a selective chemosensor with the lowest LOD for Hg ions in water-rich medium: implications for on-site detection and logic gate experiments.

RSC advances·2026
Same author

NSH76: a selective inhibitor of RRN3 and RNA polymerase I transcription with potential for cancer therapy.

Journal of translational medicine·2025
Same author

Flooded with potential: urban drainage science as seen by early-career researchers.

Water science and technology : a journal of the International Association on Water Pollution Research·2025
Same author

Uninostril endonasal trans-sphenoidal approach for pituitary macroadenoma-Operative nuances step by step.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2024
Same author

Retraction Note: IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer.

Oncogene·2024
Same author

Correlation of Transient Elastography with Liver Iron Concentration and Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia Major from Oman.

Mediterranean journal of hematology and infectious diseases·2023

Related Experiment Video

Updated: Jul 8, 2026

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Modeling and informatics in designing anti-diabetic agents.

P V Bharatam1, D S Patel, L Adane

  • 1Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar (Mohali)-160 062, Punjab, India. pvbharatam@niper.ac.in

Current Pharmaceutical Design
|January 29, 2008
PubMed
Summary
This summary is machine-generated.

This review explores rational approaches for designing new anti-diabetic agents for type 2 diabetes mellitus (T2DM). It highlights the use of in silico methods targeting key molecular pathways.

More Related Videos

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on: May 10, 2024

Related Experiment Videos

Last Updated: Jul 8, 2026

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on: May 10, 2024

Area of Science:

  • Pharmacology
  • Computational Chemistry
  • Bioinformatics

Background:

  • Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by impaired glucose regulation.
  • Current T2DM therapies include metformin, glitazones, and sulfonylureas.
  • Extensive research focuses on molecular targets like PPARgamma, PTP1B, and DPP-IV for novel anti-diabetic drug development.

Purpose of the Study:

  • To review rational approaches in designing anti-diabetic agents.
  • To emphasize the role of in silico methodologies in drug discovery for T2DM.
  • To showcase exemplary studies and their transferable methodologies.

Main Methods:

  • In silico analysis of molecular targets for T2DM.
  • Molecular modeling techniques including molecular docking and pharmacophore mapping.
  • Quantitative Structure-Activity Relationship (QSAR) studies, virtual screening, and bioinformatics/chemoinformatics approaches.

Main Results:

  • Numerous molecular targets for T2DM have been identified and studied.
  • In silico methods are crucial for analyzing these targets and associated drug leads.
  • Exemplary studies demonstrate the effectiveness of computational approaches in anti-diabetic drug design.

Conclusions:

  • In silico studies provide powerful tools for rational anti-diabetic drug design.
  • Methodologies used in T2DM research can be applied to other therapeutic areas.
  • Computational approaches accelerate the discovery of novel anti-diabetic agents.